CrossrefInfokarte
Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE® to Provide Two Distinct and Complementary Perspectives
Patient Related Outcome Measures · 2022-12 · Volume 13 · 249-258
DOI: 10.2147/prom.s256567 ↗Abstract
Kein Abstract verfügbar.
EUVIMED